VALSE: Integration of Neuromodulation and Exoskeleton Systems for Mobility in Individuals With Chronic Spinal Cord Injury
A legfontosabb adatok
- Ki végzi
- Ecole Polytechnique Fédérale de Lausanne
- Hol
- Svájc1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Toborzás még nem indult
- Résztvevők
- 12 fő, tervezett
- Kezdés
- 2026. szept. 15.
- Várható befejezés
- 2028. szept.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- TWIICE Rise 1.0 robotic exoskeleton combined with epidural electrical stimulation (EES)
- A regiszteradat frissítve
- 2026. augusztus 4.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a long-standing spinal cord injury caused by an accident or trauma. They must already take part in one of three earlier CHUV studies and have a working spinal stimulation system.
- Életkor
- 18 years and older
- Nem
- All sexes
- A betegség stádiuma
- Traumatic spinal cord injury that is not getting worse, which happened at least 12 months before signing consent.
- Korábbi kezelés
- Must have finished the set phase of a parent study at CHUV: BoxSwitch (NCT05942339), Think2Go (NCT06243952) or STIMO-BSI (NCT04632290). Must have a working neuromodulation (nerve stimulation) system.
A részvétel fő kizáró okai
- Severe bone thinning on a DEXA bone scan: t-score below -3.5 at the hip, or bone density < 0.60 gm/cm2 at the knee
- Blood clot in a leg vein in the past 6 months, or a leg fracture in the last two years
- Current pressure sore on the arms, trunk, pelvis or legs, or a hip or knee that cannot straighten by more than 15°
- Serious health problems that rule out moderate to hard exercise, or an implanted life-supporting device
- Pregnancy, weight of 100 kg (220 lb) or more, or height outside 160 to 190 cm (5 ft 3 in–6 ft 3 in)
A regiszter feltételei, szó szerint
Mind a 21 feltétel megnézéseKevesebb
Ki vehet részt
- Currently enrolled participants who have completed the relevant phase of their parent study at CHUV: BoxSwitch (NCT05942339, after the optimisation phase), Think2Go (NCT06243952, after the rehabilitation phase, or STIMO-BSI (NCT04632290, after the calibration and training phase of the optional extension with system upgrade),
- Must have a functional neuromodulation system,
- Must be at least 18 years old,
- Must be suffering from non-progressive traumatic spinal cord injury, sustained at least 12 months before signing the consent form,
- Must weigh less than 100 kg,
- Must have a standing height between 160 and 190 cm,
- Must be able to grasp and lift bilateral crutches in a seated position,
- Must have stable medical, physical and psychological condition as considered by the investigator,
- Must be able to understand and interact with the study team in French or English,
- Must agree to comply in good faith with all conditions of the study and to attend all scheduled appointments,
- Must provide Informed Consent as documented by signature prior to any study-related procedures
Ki nem vehet részt
- Must not have severe concurrent medical conditions that contraindicate moderate to intense exercise (e.g., uncontrolled hypertension, coronary artery disease, congestive heart failure)
- Must not have deep vein thrombosis in lower extremities within the past 6 months
- Must not have current pressure ulcer of the arms, trunk, pelvic area, or lower extremities
- Must not be diagnosed with severe osteoporosis/penia:; Dual Energy X-ray Absorptiometry (DEXA) results indicating a t-score below -3.5 at either the femoral neck or the total proximal femur; Dual Energy X-ray Absorptiometry (DEXA) results indicating a bone mineral density (BMD) < 0.60 gm/cm2 at any knee region (distal femur, proximal tibia)
- Must not have experienced lower extremity fractures within the last two years
- Must not present with a flexion contracture >15° at the hip or knee
- Must not have heterotopic ossification that impairs joint mobility
- Must not be implanted with a life-supporting medical device (devices implanted in the parent study are not considered life-supporting),
- Must not be pregnant,
- Must not be the investigator himself, his/her family members, employees, or other dependent persons
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
The purpose of this clinical study is to evaluate the preliminary safety and feasibility of using the VALSE system, which combines spinal cord stimulation with the TWIICE robotic exoskeleton, to support motor recovery and reduce reliance on laboratory-based equipment during rehabilitation in participants with traumatic spinal cord injury. The TWIICE exoskeleton is integrated through the NR system, a platform developed by EPFL. The goal is to assess the clinical safety and practical application of this combined neuroprosthetic approach in a small number of participants, in order to guide future refinements of the device and protocol, support the development of scalable interventions integrating spinal stimulation with robotic assistance, and inform strategies for delivering rehabilitation in more accessible, real-world environments.
A vizsgálat csoportja
- All participantA vizsgált kezelés
All participants receive the same intervention. Each participant will complete 3 predefined study periods within 1 year of enrolment. Each study period lasts 3 weeks, and study periods are separated by a minimum interval of 1 month.
Kezelés: TWIICE Rise 1.0 robotic exoskeleton combined with epidural electrical stimulation (EES)
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. augusztus 4.